Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 20;15(3):e0230219.
doi: 10.1371/journal.pone.0230219. eCollection 2020.

Considering patient clinical history impacts performance of machine learning models in predicting course of multiple sclerosis

Affiliations

Considering patient clinical history impacts performance of machine learning models in predicting course of multiple sclerosis

Ruggiero Seccia et al. PLoS One. .

Abstract

Multiple Sclerosis (MS) progresses at an unpredictable rate, but predictions on the disease course in each patient would be extremely useful to tailor therapy to the individual needs. We explore different machine learning (ML) approaches to predict whether a patient will shift from the initial Relapsing-Remitting (RR) to the Secondary Progressive (SP) form of the disease, using only "real world" data available in clinical routine. The clinical records of 1624 outpatients (207 in the SP phase) attending the MS service of Sant'Andrea hospital, Rome, Italy, were used. Predictions at 180, 360 or 720 days from the last visit were obtained considering either the data of the last available visit (Visit-Oriented setting), comparing four classical ML methods (Random Forest, Support Vector Machine, K-Nearest Neighbours and AdaBoost) or the whole clinical history of each patient (History-Oriented setting), using a Recurrent Neural Network model, specifically designed for historical data. Missing values were handled by removing either all clinical records presenting at least one missing parameter (Feature-saving approach) or the 3 clinical parameters which contained missing values (Record-saving approach). The performances of the classifiers were rated using common indicators, such as Recall (or Sensitivity) and Precision (or Positive predictive value). In the visit-oriented setting, the Record-saving approach yielded Recall values from 70% to 100%, but low Precision (5% to 10%), which however increased to 50% when considering only predictions for which the model returned a probability above a given "confidence threshold". For the History-oriented setting, both indicators increased as prediction time lengthened, reaching values of 67% (Recall) and 42% (Precision) at 720 days. We show how "real world" data can be effectively used to forecast the evolution of MS, leading to high Recall values and propose innovative approaches to improve Precision towards clinically useful values.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Pearson Matrix describing the relation among input features and the transition to the SP phase within 180 days.
Fig 2
Fig 2. Threshold analysis.
The choice of confidence threshold has different effects on the indicated variables. Analysis was performed with Random Forest and LSTM for Record Preserving datasets.

Similar articles

Cited by

References

    1. Bordi I, Umeton R, Ricigliano VA, Annibali V, Mechelli R, Ristori G, et al. A mechanistic, stochastic model helps understand multiple sclerosis course and pathogenesis. Int J Genomics. 2013;2013:910321 10.1155/2013/910321 - DOI - PMC - PubMed
    1. Bergamaschi R, Montomoli C, Mallucci G BREMSO: a simple score to predict early the natural course of multiple sclerosis. Eur J Neurol. 2015; 22(6):981–989. 10.1111/ene.12696 - DOI - PubMed
    1. Galea I, Lederer C, Neuhaus A A web- based tool for personalized prediction of long- term disease course in patients with multiple sclerosis. Eur J Neurol. 2013; 20:1107–1109. 10.1111/ene.12016 - DOI - PMC - PubMed
    1. Rotstein D, Montalban X Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis. Nat Rev Neurol. 2019; 15(5):287–300. 10.1038/s41582-019-0170-8 - DOI - PubMed
    1. Guillemin F, Baumann C, Epstein J. Older age at multiple sclerosis onset is an independent factor of poor prognosis: a population- based cohort study. Neuroepidemiol. 2017; 48:79–187. 10.1159/000479516 - DOI - PubMed

Publication types